ArriVent BioPharma (AVBP) PT Raised to $39 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Jeff Jones raised the price target on ArriVent BioPharma (NASDAQ: AVBP) to $39.00 (from $35.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
